TransCode Therapeutics RNAZ
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 10.75 | 1 | -128.23 | -5 | -71.98 | 5 |
| 2025Q2 | 7.80 | 6 | -52.03 | -4 | -39.86 | 8 |
| 2025Q1 | 13.86 | 10 | -12 | -117.97 | 13 | |
| 2024Q4 | 94.36 | -2 | -6 | -105.36 | 7 | |
| 2024Q3 | 527.60 | 2 | -156.09 | -2 | -52.98 | 4 |
| 2024Q2 | 928.62 | 1 | -175.79 | -5 | -85.70 | 5 |
| 2024Q1 | 631.09 | 5 | -106.89 | -3 | -53.40 | 7 |
| 2023Q4 | 6091.01 | 2 | -134.45 | -4 | -53.10 | 5 |
| 2023Q3 | 18579.79 | 4 | -162.28 | -5 | -65.80 | 10 |
| 2023Q2 | 85008.00 | 2 | -4 | -75.69 | 6 | |
| 2023Q1 | 250219.20 | 0 | -5 | -73.10 | 6 | |
| 2022Q4 | 497481.60 | 3 | -89.40 | -5 | -52.38 | 8 |
| 2022Q3 | 813120.00 | 8 | -41.51 | -4 | -32.78 | 12 |
| 2022Q2 | 931392.00 | 12 | -31.74 | -5 | -28.30 | 14 |
| 2022Q1 | 2128896.00 | 17 | -18.55 | -3 | -16.61 | 19 |
| 2021Q4 | 1877568.00 | 20 | -12.85 | -3 | -11.59 | 23 |
| 2021Q3 | 2210208.00 | 23 | -2 | -17.34 | 25 | |
| 2021Q2 | -5 | 3 | 216.48 | 2 | ||
| 2021Q1 | -8 | -4 | -428.57 | 1 | ||
| 2020Q4 | -3 | -1 | 1 |